Cargando…

Implementing a Novel Statewide Network to Support Emergency Department-initiated Buprenorphine Treatment

INTRODUCTION: Medications for opioid use disorder (MOUD), including buprenorphine, represent an evidence-based treatment that supports long-term recovery and reduces risk of overdose death. Patients in crisis from opioid use disorder (OUD) often seek care from emergency departments (ED). The New Yor...

Descripción completa

Detalles Bibliográficos
Autores principales: Clemency, Brian M., Hoopsick, Rachel A., Burnett, Susan J., Kahn, Linda S., Lynch, Joshua J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Department of Emergency Medicine, University of California, Irvine School of Medicine 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391018/
https://www.ncbi.nlm.nih.gov/pubmed/35980408
http://dx.doi.org/10.5811/westjem.2022.3.54680
_version_ 1784770777079349248
author Clemency, Brian M.
Hoopsick, Rachel A.
Burnett, Susan J.
Kahn, Linda S.
Lynch, Joshua J.
author_facet Clemency, Brian M.
Hoopsick, Rachel A.
Burnett, Susan J.
Kahn, Linda S.
Lynch, Joshua J.
author_sort Clemency, Brian M.
collection PubMed
description INTRODUCTION: Medications for opioid use disorder (MOUD), including buprenorphine, represent an evidence-based treatment that supports long-term recovery and reduces risk of overdose death. Patients in crisis from opioid use disorder (OUD) often seek care from emergency departments (ED). The New York Medication for Addiction Treatment and Electronic Referrals (MATTERS) network is designed to support ED-initiated buprenorphine and urgent referrals to long-term care for patients suffering from OUD. METHODS: Using the PRECEDE-PROCEED implementation science framework, we provide an overview of the creation of the MATTERS network in Western New York. We also include an explanation of how the network was designed and launched as a response to the opioid epidemic. Finally, we analyzed the program’s outputs and outcomes, thus far, as it continues to grow across the state. RESULTS: The New York MATTERS network was created and implemented in 2019 with a single hospital referring patients with OUD to three local clinics. In the social assessment and situational analysis phase, we describe the opioid epidemic and available resources in the region at the outset of the program. In the epidemiological assessment phase, we quantify the epidemic on the state and regional levels. In the educational and ecological assessment, we review local ED practices and resources. In the administrative and policy assessment and intervention alignment phase, the program’s unique framework is reviewed. In the piloting phase, we describe the initial deployment of New York MATTERS. Finally, in the process evaluation phase, we depict the early lessons we learned. By the beginning of 2021, the New York MATTERS network included 35 hospitals that refer to 47 clinics throughout New York State. CONCLUSION: The New York MATTERS network provides a structured approach to reduce barriers to ED-initiated buprenorphine and urgent referral to long-term care. An implementation framework provides a structured means of evaluating this best practice model.
format Online
Article
Text
id pubmed-9391018
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Department of Emergency Medicine, University of California, Irvine School of Medicine
record_format MEDLINE/PubMed
spelling pubmed-93910182022-08-22 Implementing a Novel Statewide Network to Support Emergency Department-initiated Buprenorphine Treatment Clemency, Brian M. Hoopsick, Rachel A. Burnett, Susan J. Kahn, Linda S. Lynch, Joshua J. West J Emerg Med Behavioral Health INTRODUCTION: Medications for opioid use disorder (MOUD), including buprenorphine, represent an evidence-based treatment that supports long-term recovery and reduces risk of overdose death. Patients in crisis from opioid use disorder (OUD) often seek care from emergency departments (ED). The New York Medication for Addiction Treatment and Electronic Referrals (MATTERS) network is designed to support ED-initiated buprenorphine and urgent referrals to long-term care for patients suffering from OUD. METHODS: Using the PRECEDE-PROCEED implementation science framework, we provide an overview of the creation of the MATTERS network in Western New York. We also include an explanation of how the network was designed and launched as a response to the opioid epidemic. Finally, we analyzed the program’s outputs and outcomes, thus far, as it continues to grow across the state. RESULTS: The New York MATTERS network was created and implemented in 2019 with a single hospital referring patients with OUD to three local clinics. In the social assessment and situational analysis phase, we describe the opioid epidemic and available resources in the region at the outset of the program. In the epidemiological assessment phase, we quantify the epidemic on the state and regional levels. In the educational and ecological assessment, we review local ED practices and resources. In the administrative and policy assessment and intervention alignment phase, the program’s unique framework is reviewed. In the piloting phase, we describe the initial deployment of New York MATTERS. Finally, in the process evaluation phase, we depict the early lessons we learned. By the beginning of 2021, the New York MATTERS network included 35 hospitals that refer to 47 clinics throughout New York State. CONCLUSION: The New York MATTERS network provides a structured approach to reduce barriers to ED-initiated buprenorphine and urgent referral to long-term care. An implementation framework provides a structured means of evaluating this best practice model. Department of Emergency Medicine, University of California, Irvine School of Medicine 2022-07 2022-06-05 /pmc/articles/PMC9391018/ /pubmed/35980408 http://dx.doi.org/10.5811/westjem.2022.3.54680 Text en Copyright: © 2022 Clemency et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) License. See: http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Behavioral Health
Clemency, Brian M.
Hoopsick, Rachel A.
Burnett, Susan J.
Kahn, Linda S.
Lynch, Joshua J.
Implementing a Novel Statewide Network to Support Emergency Department-initiated Buprenorphine Treatment
title Implementing a Novel Statewide Network to Support Emergency Department-initiated Buprenorphine Treatment
title_full Implementing a Novel Statewide Network to Support Emergency Department-initiated Buprenorphine Treatment
title_fullStr Implementing a Novel Statewide Network to Support Emergency Department-initiated Buprenorphine Treatment
title_full_unstemmed Implementing a Novel Statewide Network to Support Emergency Department-initiated Buprenorphine Treatment
title_short Implementing a Novel Statewide Network to Support Emergency Department-initiated Buprenorphine Treatment
title_sort implementing a novel statewide network to support emergency department-initiated buprenorphine treatment
topic Behavioral Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391018/
https://www.ncbi.nlm.nih.gov/pubmed/35980408
http://dx.doi.org/10.5811/westjem.2022.3.54680
work_keys_str_mv AT clemencybrianm implementinganovelstatewidenetworktosupportemergencydepartmentinitiatedbuprenorphinetreatment
AT hoopsickrachela implementinganovelstatewidenetworktosupportemergencydepartmentinitiatedbuprenorphinetreatment
AT burnettsusanj implementinganovelstatewidenetworktosupportemergencydepartmentinitiatedbuprenorphinetreatment
AT kahnlindas implementinganovelstatewidenetworktosupportemergencydepartmentinitiatedbuprenorphinetreatment
AT lynchjoshuaj implementinganovelstatewidenetworktosupportemergencydepartmentinitiatedbuprenorphinetreatment